Cargando…

Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo

BACKGROUND: Cisplatin-based chemotherapy is the first-line treatment for ovarian cancer. However, acquired resistance to cisplatin treatment often occurs in epithelial ovarian cancer, and effective and practical methods for overcoming this obstacle are urgently needed. The study aimed to demonstrate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Bo, Xia, Meng, Wang, Bin, Thapa, Niresh, Gan, Lijuan, Sun, Chaoyang, Guo, Ensong, Huang, Jia, Lu, Yulan, Cai, Hongbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839134/ https://www.ncbi.nlm.nih.gov/pubmed/31703731 http://dx.doi.org/10.1186/s13048-019-0570-9

Ejemplares similares

In vitro synergism of fosfomycin and clarithromycin antimicrobials against methicillin-resistant Staphylococcus pseudintermedius
por: DiCicco, Matthew, et al.
Publicado: (2014)

HSP27 Knockdown Increases Cytoplasmic p21 and Cisplatin Sensitivity in Ovarian Carcinoma Cells
por: Lu, Hao, et al.
Publicado: (2016)

Preparation and In Vitro, In Vivo Evaluation of Clarithromycin Microcapsules
por: Hu, Liandong, et al.
Publicado: (2010)

In Vitro and In Vivo Evaluation of Niosomal Formulation for Controlled Delivery of Clarithromycin
por: Shilakari Asthana, Gyati, et al.
Publicado: (2016)

Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance
por: Iannelli, Federica, et al.
Publicado: (2020)

Piperlongumine Induces Apoptosis and Synergizes with Cisplatin or Paclitaxel in Human Ovarian Cancer Cells
por: Gong, Li-Hua, et al.
Publicado: (2014)

A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients
por: Sun, Chaoyang, et al.
Publicado: (2019)

Correction to: A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients
por: Sun, Chaoyang, et al.
Publicado: (2020)

NVP-BEZ235 synergizes cisplatin sensitivity in osteosarcoma
por: Huang, Jin-Cheng, et al.
Publicado: (2017)

Cyclin-dependent kinase inhibitor dinaciclib potently synergizes with cisplatin in preclinical models of ovarian cancer
por: Chen, Xiu-Xiu, et al.
Publicado: (2015)

Cisplatin and CCNU synergism in spheroid cell subpopulations.
por: Durand, R. E.
Publicado: (1990)

The synergic effect of vincristine and vorinostat in leukemia in vitro and in vivo
por: Chao, Min-Wu, et al.
Publicado: (2015)

Granulin A Synergizes with Cisplatin to Inhibit the Growth of Human Hepatocellular Carcinoma
por: Qiao, Gan, et al.
Publicado: (2018)

Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines
por: Moorsel, C J A van, et al.
Publicado: (1999)

Sulforaphane regulates apoptosis- and proliferation-related signaling pathways and synergizes with cisplatin to suppress human ovarian cancer
por: Kan, Shi-Feng, et al.
Publicado: (2018)

Anlotinib Exerts Inhibitory Effects against Cisplatin-Resistant Ovarian Cancer In Vitro and In Vivo
por: Ji, Yurou, et al.
Publicado: (2022)

The biodiversity Composition of Microbiome in Ovarian Carcinoma Patients
por: Zhou, Bo, et al.
Publicado: (2019)

Vancomycin and Clarithromycin Show Synergy against Mycobacterium abscessus In Vitro
por: Mukherjee, Devika, et al.
Publicado: (2017)

Rifaximin potentiates clarithromycin against Mycobacterium abscessus in vitro and in zebrafish
por: Goh, Boon Chong, et al.
Publicado: (2023)

In Vitro Study of Synergic Effect of Cisplatin and Low Molecular Weight Heparin on Oral Squamous Cell Carcinoma
por: Camacho-Alonso, Fabio, et al.
Publicado: (2020)

Enhanced antitumor efficacy of cisplatin for treating ovarian cancer in vitro and in vivo via transferrin binding
por: Peng, Huifang, et al.
Publicado: (2017)

The inhibitory effect of 6-gingerol and cisplatin on ovarian cancer and antitumor activity: In silico, in vitro, and in vivo
por: Salari, Zohreh, et al.
Publicado: (2023)

Prognostic Significance of Log(CA125)/PCI for the Resectability of Epithelial Ovarian Cancer: A Retrospective Study
por: He, Can, et al.
Publicado: (2020)

Beneficial ex vivo immunomodulatory and clinical effects of clarithromycin in COVID-19
por: Snow, Timothy Arthur Chandos, et al.
Publicado: (2022)

Inhibition of DNA-PK by gefitinib causes synergism between gefitinib and cisplatin in NSCLC
por: Pan, Chi, et al.
Publicado: (2020)

Effects of paclitaxel and cisplatin on in vitro ovarian follicle development
por: Kim, Yoon Young, et al.
Publicado: (2019)

Suppression of nitric oxide production from nasal fibroblasts by metabolized clarithromycin in vitro
por: Furuya, Ayako, et al.
Publicado: (2010)

Dendrogenin A Synergizes with Cytarabine to Kill Acute Myeloid Leukemia Cells In Vitro and In Vivo
por: Serhan, Nizar, et al.
Publicado: (2020)

In Vitro and In Vivo Studies of Oritavancin and Fosfomycin Synergism against Vancomycin-Resistant Enterococcus faecium
por: Lagatolla, Cristina, et al.
Publicado: (2022)

Clarithromycin Solid Lipid Nanoparticles for Topical Ocular Therapy: Optimization, Evaluation, and In Vivo Studies
por: Nair, Anroop B., et al.
Publicado: (2021)

Synergic Effect of α-Mangostin on the Cytotoxicity of Cisplatin in a Cervical Cancer Model
por: Pérez-Rojas, Jazmin M., et al.
Publicado: (2016)

The ferroptosis inducer erastin irreversibly inhibits system x(c)− and synergizes with cisplatin to increase cisplatin’s cytotoxicity in cancer cells
por: Sato, Mami, et al.
Publicado: (2018)

Fixed drug eruption due to clarithromycin
por: Malkarnekar, Santoshi Balkrishna, et al.
Publicado: (2013)

Successful Treatment of Eosinophilic Gastroenteritis with Clarithromycin
por: Ohe, Masashi, et al.
Publicado: (2012)

Clarithromycin Culprit of Benign Intracranial Hypertension
por: Khan, Habib Rehman, et al.
Publicado: (2015)

Clarithromycin-induced Seizures and Status Epilepticus
por: Seetharam, Raghavendra, et al.
Publicado: (2021)

KCNN4 and S100A14 act as predictors of recurrence in optimally debulked patients with serous ovarian cancer
por: Zhao, Haiyue, et al.
Publicado: (2016)

Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus
por: Bich Hanh, Bui Thi, et al.
Publicado: (2021)

In vitro efficacy of daptomycin and teicoplanin combined with ethanol, clarithromycin or gentamicin as catheter lock solutions
por: Parra, Diego, et al.
Publicado: (2015)

In Vitro Synergy Testing of Eravacycline in Combination with Clarithromycin and Rifabutin against Mycobacterium abscessus Complex
por: Chew, Ka Lip, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_afd5r28o6pcf3g1ekh944alrou